Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rangering i aksjer #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Aksjekurs
$0.1559364
Sist synkronisert: 2026-09-18
Markedsverdi
$195.17K
Endring (1 dag)
6.60%
Endring (1 år)
-30.91%
Land
GB
Handel Fusion Antibodies plc (FAB)

Kategori

Historikk for aksjesplitt for Fusion Antibodies plc (FAB)
Aksjen Fusion Antibodies plc (symbol: FAB) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 20, 2026.
Én FAB-aksje kjøpt før Sep 20, 2026 tilsvarer i dag 0 FAB-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH